A new concept for the noncovalent binding of a ruthenium-based olefin metathesis catalyst to polymeric phases: Preparation of a catalyst on Raschig rings

Journal of the American Chemical Society

Volumn 128, Issue 40, 2006, Pages 13261-13267

  Michrowska, Anna ^a,d   Mennecke, Klaas ^b   Kunz, Ulrich ^c   Kirschning, Andreas ^b   Grela, Karol ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Poland)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^c CLAUSTHAL UNIVERSITY OF TECHNOLOGY   (Germany)

^d MAX PLANCK INSTITUT FÜR KOHLENFORSCHUNG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLASS POLYMER COMPOSITES; LIGANDS; METATHESIS CATALYST; RASCHIG RINGS;

CATALYST ACTIVITY; CHEMICAL BONDS; ELECTRON MOBILITY; MOLECULAR STRUCTURE; POLYMERIZATION; POLYSTYRENES; RUTHENIUM COMPOUNDS;

OLEFINS;

ALKENE DERIVATIVE; AMINE; AMMONIUM DERIVATIVE; BENZYLIDENE DERIVATIVE; CARBENE; GLASS; LIGAND; POLYMER; POLYSTYRENE; RUTHENIUM; SULFONE DERIVATIVE;

ARTICLE; CATALYST; COMPLEX FORMATION; MOLECULAR SIZE; POLYMERIZATION; POROSITY; PRECIPITATION; PROTON TRANSPORT; REACTION ANALYSIS; RING CLOSING METATHESIS;

EID: 33749523396     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja063561k     Document Type: Article

References (90)

1. General reviews: (a) Schrock, R. R.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2003, 42, 4592-4633.
2. (b) Trnka, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34, 18-29.
3. (c) Fürstner, A. Angew. Chem., Int. Ed. 2000, 39, 3012-3043.
4. (d) Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413-4450.
5. (e) Schuster, M.; Blechert, S. Angew. Chem., Int. Ed. Engl. 1997, 36, 2037-2056.
6. (f) Dragutan, V.; Dragutan, I.; Balaban, A. T. Platinum Met. Rev. 2001, 45, 155-163.
7. For approaches where ruthenium impurities are removed by addition of various scavengers, see (a) Maynard, H. D.; Grubbs, R. H. Tetrahedron Lett. 2000, 40, 4137-4140.
8. (b) Raquette, L. A.; Schloss, J. D.; Efremov, I.; Fabris, F.; Gallou, Mendez-Andino, J.; Yang, J. Org. Lett. 2000, 2, 1259-1261.
9. (c) Ahn, Y. M.; Yang, K.; Georg, G. I. Org. Lett. 2001, 3, 1411-1413.
10. (d) For a recent example of use of biphasic extraction of ruthenium remains in preparation of hepatitis C antiviral agent BILN 2061, see WO 2004/089974 A1 (2004, Boehringer Ingelheim International GmbH),
11. (e) For a phase separation approach, see Michrowska, A.; Gułajski, L.; Grela, K. Chem. Commun. 2006, 841-843
12. Reviews on polymer-bound reagents and catalysts: (a) Solodenko, W.; Frenzel, T.; Kirschning, A. In Polymeric Materials in Organic Synthesis and Catalysis; Buchmeiser, M. R., Ed.; Wiley-VCH: Weinheim, 2003; pp 201-240.
13. (b) Clapham, B.; Reger, T. S.; Janda, K. D. Tetrahedron 2001, 57, 4637-4662.
14. (c) Baxendale, I. R.; Storer, R. I.; Ley, S V. In Polymeric Materials in Organic Synthesis and Catalysis; Buchmeiser, M. R., Ed.; Wiley-VCH: Weinheim, 2003; pp 53-132.
15. (d) Kirschning, A.; Monenschein, H.; Wittenberg, R. Angew. Chem., Int. Ed. 2001, 40, 650-679.
16. (e) Ley, S. V.; Baxendale, I. R.; Bream, R. N.; Jackson, P. S.; Leach, A. G. Longbottom, D. A.; Nesi, M.; Scott, J. S.; Storer, R. I.; Taylor, S. J. J. Chem. Soc., Perkin Trans. 1 2000, 3815-4195.
17. (f) Drewry, D. H.; Coe, D. M.; Poon, S. Med. Res. Rev. 1999, 19, 97-148.
18. Reviews: (a) Kingsbury, J. S.; Hoveyda, A. H. In Polymeric Materials in Organic Synthesis and Catalysis; Buchmeiser, M. R., Ed.; Wiley-VCH: Weinheim, 2003; p 467.
19. (b) Buchmeiser, M. R. New J. Chem. 2004, 28, 549-557.
20. (a) Kingsbury, J. S.; Harrity, J. P. A.; Bonitatebus, P. J.; Hoveyda, A. H. J. Am. Chem. Soc, 1999, 121, 791-799.
21. (b) Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 8168-8179.
22. (a) For a short review, see Hoveyda, A. H.; Gillingham, D. G.; Van Veldhuizen, J. J.; Kataoka, O.; Garber, S. B.; Kingsbury, J. S.; Harrity, J. P. A. Org. Biomol. Chem. 2004, 2, 1-16.
23. For syntheses of supported variants of 3-4, see inter alia: (a) Kingsbury, J. S.; Garber, S. B.; Giftos, J. M.; Gray, B. L.; Okamoto, M. M.; Farrer, R. A.; Fourkas, J. T.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2001, 40, 4251-4256.
24. (b) Grela, K.; Tryznowski, M.; Bieniek, M. Tetrahedron Lett. 2002, 43, 9055-9059.
25. (c) Connon, S. J.; Dunne, A. M.; Blechert, S. Angew. Chem., Int. Ed. 2002, 41, 3835-3838.
26. (d) Dowden, J.; Savovic, J. Chem. Commun. 2001, 37-38.
27. (e) Yao, Q. Angew. Chem., Int. Ed. 2000, 39, 3896-3898.
28. (f) Yao, Q.; Zhang, Y. Angew. Chem., Int. Ed. 2003, 42, 3395-3398.
29. (g) Connon, S. J.; Blechert, S. Bioorg. Med. Chem. Lett. 2002, 12, 1873-1876.
30. (h) Yao, Q.; Zhang, Y. J. Am. Chem. Soc. 2004, 12, 74-75.
31. (i) Yao, Q.; Motta, A. R. Tetrahedron Lett. 2004, 45, 2447-2451.
32. (j) Yang, L.; Mayr, M.; Wurst, K.; Buchmeiser M. R. Chem. Eur. J. 2004, 10, 5761-5770.
33. (k) Krause, J. O.; Nuyken, O.; Wurst, K.; Buchmeiser, M. R. Chem. Eur. J. 2004, 10, 777-784.
34. (l) Krause, J. O.; Zarka, M. T.; Anders, U.; Weberskirch, R.; Nuyken, O.; Buchmeiser, M. R. Angew. Chem., Int. Ed. 2003, 42, 5965-5969.
35. (m) Audic, N.; Clavier, H.; Mauduit, M.; Guillemin, J.-C. J. Am. Chem. Soc. 2003, 125, 9248-9249.
36. (n) Clavier, H.; Audic, N.; Mauduit, M.; Guillemin, J.-C. G. Chem. Commun. 2004, 282-284.
37. (a) Kirschning, A.; Jas, G. Top. Curr. Chem. 2004, 242, 209-241.
38. (b) Jas, G.; Kirschning, A. Chem. Eur. J. 2003, 9, 5708-5723.
39. (c) Fletcher, P. D. I.; Haswell, S. J.; Pombo-Villar, E.; Warrington, B. H.; Watts, P.; Wong, S. Y.; Zhang, X. Tetrahedron 2002, 58, 4735-4757.
40. (d) Kirschning, A.; Solodenko, W.; Mennecke, K. Chem. Eur. J. 2006, 12, 5972-5990.
41. Kunz, U.; Leue, S.; Stuhlmann, F.; Sourkouni-Argirusi, G.; Wen, H.; Jas, G.; Kirschning, A. Eur. J. Org. Chem. 2004, 3601-3610.
42. Schöning, K. U.; End, N.; Top. Curr. Chem. 2004, 242, 241-273 and 273-319.
43. For an excellent review on strategies of noncovalent immobilization of catalysts refer to Horn, J.; Michalek, F.; Tzschucke, C. C.; Bannwarth, W. Top. Curr. Chem. 2004, 242, 43-77.
44. Fraile, J. M.; Garcia, J. I.; Herrerías, C. I.; Mayoral, J. A.; Reiser, O.; Socuéllamos, A.; Werner, H. Chem. Eur. J. 2004, 10, 2997-3005.
45. Mehnert, C. P. Chem. Eur. J. 2004, 14, 50-56.
46. (a) Mehnert, C. P.; Mozeleski, E. J.; Cook, R. A. Chem. Commun. 2002, 3010-3011.
47. (b) Hagiwara, H. Sugawara, Y.; Isobe, K.; Hoshi, T.; Suzuki, T. Org. Lett. 2004, 6, 2325-2328.
48. (c) Gruttadauri, M.; Riela, S.; Meo, P. L.; Dánna, F.; Noto, R. Tetrahedron Lett. 2004, 45, 6113-6116.
49. Mennecke, K.; Grela, K.; Kunz, U.; Kirschning, A. Synlett 2005, 2948-2952.
50. Grela, K.; Harutyunyan, S.; Michrowska, A. Angew. Chem., Int. Ed. 2002, 41, 4038-4040;
51. Angew. Chem. 2002, 114, 4210-4212.
52. (a) Michrowska, A.; Bujok, R.; Harutyunyan, S.; Sashuk, V.; Dolgonos, G.; Grela, K. J. Am. Chem. Soc. 2004, 126, 9318-9325.
53. (b) Grela K. Boehringer Ingelheim International, U.S. Patent 6,867,303, 2005. For applications of catalyst 6a and 6b,
54. see (c) Ostrowski, S.; Mikus, A. Mol. Divers 2003, 6, 315-321.
55. (d) Honda, T.; Namiki, H.; Kaneda, K.; Mizutani, H. Org. Lett. 2004, 6, 87-89.
56. (e) Honda, T.; Namiki, H.; Watanabe, M.; Mizutani, H. Tetrahedron Lett. 2004, 45, 5211-5213.
57. (f) Stellfeld, T.; Bhatt, U.; Kalesse, M. Org. Lett. 2004, 6, 3889-3892.
58. (g) Albert, B. J.; Sivaramakrishnan, A.; Naka, T.; Koide, K. J. Am. Chem. Soc. 2006, 128, 2792-2793.
59. (h) For a recent application in the synthesis of hepatitis C antiviral agent Ciluprevir (BILN 2061), see WO 2004/089974 A1, Boehringer Ingelheim International GmbH, 2004.
60. Mikus, A.; Sashuk, V.; Kedziorek, M.; Samojłowicz, C.; Ostrowski, S.; Grela, K. Synlett 2005, 1142-1146.
61. (j) Vinokurov, N.; Michrowska, A.; Szmigielska, A.; Drzazga, Z.; Wojciuk, G.; Demchuk, O. M.; Grela, K.; Pietrusiewicz, K. M.; Butenschön, H. Adv. Synth. Catal. 2006, 348, 931-938.
62. (a) Michrowska, A. Ph.D. Thesis, Institute of Organic Chemistry, Polish Academy of Sciences, Warsaw, Poland, 2006.
63. (b) For a preliminary study on activation of 7 and other complexes, see Gułajski, L.; Michrowska, A.; Bujok, R.; Grela, K. J. Mol. Catal. A: Chem. 2006, 348, 931-938.
64. (a) For water-soluble Grubbs ruthenium alkylidenes bearing quarternary ammonium salts, see Lynn, D. M.; Mohr, B.; Grubbs, R. H.; Henling, L. M.; Day, M. W. J. Am. Chem. Soc. 2000, 122, 6601-6609.
65. (b) For an example of a catalytically active ruthenium allenylidene complex bearing a Me2N group see Fürstner, A.; Liebl, M.; Lehmann, C.; Piquet, M.; Kunz, R.; Bruneau, C.; Touchard, D.; Dixneuf, P. H. Chem. Eur. J. 2000, 6, 10, 1847-1857.
66. Hodge, P. Chem. Soc. Rev. 1997, 26, 417-424 and references therein.
67. Kunz, U.; Kirschning, A.; Hoffmann, U. EP 1268566 B1, 2004.
68. Alternate immobilization procedures relied on mixing catalyst 4 and ligand 9 (1:1) in the presence of cationic exchange resins to reduce leaching during RCM by trapping the active Ru species by the ligand. This procedure did not give improved results: 1st run 98%, 2nd run 82%, 3rd run 45%, 4th run 38%, 5th run 8%.
69. (a) Kirschning, A.; Altwicker, C.; Dräger, G.; Harders, J.; Hoffmann, N.; Hoffmann, U.; Schönfeld, H.; Solodenko, W.; Kunz, U. Angew. Chem., Int. Ed. 2001, 40, 3995-3998.
70. (b) Kunz, U.; Schönfeld, H.; Solodenko, W.; Jas, G.; Kirschning, A. Ind. Eng. Chem. Res. 2005, 44, 8458-8467.
71. (a) Solodenko, W.; Kunz, U.; Kirschning, A. Bioorg. Med. Chem. Lett. 2002, 12, 1833-1835.
72. (b) Kunz, U.; Kirschning, A.; Altwicker, C.; Solodenko, W. J. Chromatogr. A 2003, 1006, 241-249.
73. This aspect is of particular importance when continuous flow processes are envisaged.
74. Mayr, M.; Wang, D.; Kröll, R.; Schuler, N.; Prühs, S.; Fürstner, A.; Buchmeiser, M. R. Adv. Synth. Catal. 2005, 347, 484-492.
75. 2O, and methanol. Then fresh catalyst 7 was loaded as described above and the "recharged" ring was used in the next cycle of metathesis. This experiment gave the following results: Initial catalyst, loading 3.0 μmol/ring, conversion 99%; 1st recharging, loading 3.0 μmol/ring, conversion 87%; 2nd recharging, loading 3.0 μmol/ring, conversion >99%; 3rd recharging, loading 2.8 μmol/ring, conversion 99%. See the Supporting Information for details.
76. For high-throughput experiments described in Table 1 the Radleys 12 Place Heated Carousel Reaction Station (www.radleys.com) was used.
77. (a) Michalak, K.; Michalak, M.; Wicha, J. Tetrahedron Lett. 2005, 46, 1149-1153.
78. (b) Michalak, M., Wicha, J. Synlett 2005, 2277-2280.
79. (a) Review: Uma, R.; Crevisy, C.; Gree, R. Chem. Rev. 2003, 103, 27-52.
80. (b) Alcaide, B.; Almendros, P. Chem. Eur. J. 2003, 9, 1258-1262.
81. (c) Schmidt, B. J. Org. Chem. 2004, 69, 7672-7687
82. (d) Arisawa, M.; Terada, Y.; Nakagawa, M.; Nishida, A. Angew. Chem. 2002, 114, 4926-4928.
83. (e) Gurjar, M. K.; Yakambram, P. Tetrahedron Lett. 2001, 42, 3633-3636.
84. (f) Braddock, D. C.; Wildsmith, A. J. Tetrahedron Lett. 2001, 42, 3239-3242.
85. (f) Hoye, T. R.; Zhao, H. Org. Lett. 1999, 1, 1123-1125.
86. Interestingly, in the case of 5 immobilized on polyvinyl pyridine, exclusive C-C double bond isomerization instead of CM was observed for this substrate: ref 15.
87. (a) Chen, G.-w.; Kirschning, A. Chem. Eur. J. 2002, 8, 2717-2729.
88. (b) Kirschning, A.; Chen, G.-w.; Jaunzems, J.; Jesberger, M.; Kalesse, M.; Lindner, M. Tetrahedron 2004, 60, 3505-3521.
89. The high activity of catalyst 7C has also been confirmed at Solvay GmbH by its application in CM of allylated steroids with α,β-unsaturated partners: Messinger, J.; Schön, U.; Mennecke, K.; Harmrohlf, K.; Kirschning, A. unpublished results.
90. It has been recently demonstrated that free Ru carbene intermediates in solution can be scavenged by monolithic sol-gel glass-bound styrene ether ligands prior to the onset of competing transition metal decomposition. See Kingsbury, J. S.; Hoveyda, A. H. J. Am. Chem. Soc. 2005, 127, 4510-4517.